BIOCON
|
BIOCON Last 5 Year Balance Sheet History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
EQUITY AND LIABILITIES | |||||
Share Capital | ₹600 Cr | ₹600 Cr | ₹600 Cr | ₹600 Cr | ₹600 Cr |
Equity - Authorised | ₹625 Cr | ₹625 Cr | ₹625 Cr | ₹625 Cr | ₹625 Cr |
Equity - Issued | ₹600 Cr | ₹600 Cr | ₹600 Cr | ₹600 Cr | ₹600 Cr |
Equity Paid Up | ₹600 Cr | ₹600 Cr | ₹600 Cr | ₹600 Cr | ₹600 Cr |
Equity Shares Forfeited | - | - | - | - | - |
Adjustments to Equity | - | - | - | - | - |
Preference Capital Paid Up | - | - | - | - | - |
Face Value | ₹5.00 | ₹5.00 | ₹5.00 | ₹5.00 | ₹5.00 |
Share Warrants & Outstandings | ₹425 Cr | ₹320 Cr | ₹274 Cr | ₹204 Cr | ₹154 Cr |
Total Reserves | ₹20,619 Cr | ₹18,863 Cr | ₹16,993 Cr | ₹7,628 Cr | ₹6,873 Cr |
Securities Premium | ₹258 Cr | ₹229 Cr | ₹174 Cr | ₹119 Cr | ₹62 Cr |
Capital Reserves | ₹84 Cr | ₹84 Cr | ₹80 Cr | ₹80 Cr | ₹80 Cr |
Profit & Loss Account Balance | ₹18,959 Cr | ₹17,603 Cr | ₹16,086 Cr | ₹6,827 Cr | ₹6,236 Cr |
General Reserves | ₹188 Cr | ₹188 Cr | ₹162 Cr | ₹162 Cr | ₹162 Cr |
Other Reserves | ₹1,130 Cr | ₹760 Cr | ₹491 Cr | ₹440 Cr | ₹333 Cr |
Reserve excluding Revaluation Reserve | ₹20,618 Cr | ₹18,862 Cr | ₹16,992 Cr | ₹7,627 Cr | ₹6,872 Cr |
Revaluation reserve | ₹0.90 Cr | ₹0.90 Cr | ₹0.90 Cr | ₹0.90 Cr | ₹0.90 Cr |
Shareholder's Funds | ₹21,644 Cr | ₹19,784 Cr | ₹17,867 Cr | ₹8,433 Cr | ₹7,627 Cr |
Minority Interest | ₹6,069 Cr | ₹5,491 Cr | ₹4,622 Cr | ₹1,038 Cr | ₹881 Cr |
Long-Term Borrowings | - | - | - | - | - |
Secured Loans | ₹10,503 Cr | ₹11,268 Cr | ₹13,692 Cr | ₹2,574 Cr | ₹1,492 Cr |
Non Convertible Debentures | ₹8,787 Cr | ₹1,832 Cr | ₹1,292 Cr | ₹200 Cr | ₹200 Cr |
Converible Debentures & Bonds | - | - | - | - | - |
Packing Credit - Bank | - | - | - | - | - |
Inter Corporate & Security Deposit | - | - | - | - | - |
Term Loans - Banks | ₹3,611 Cr | ₹10,083 Cr | ₹12,400 Cr | ₹2,384 Cr | ₹2,095 Cr |
Term Loans - Institutions | - | - | - | - | - |
Other Secured | ₹-1,895 Cr | ₹-648 Cr | - | ₹-9.50 Cr | ₹-803 Cr |
Unsecured Loans | ₹1,903 Cr | ₹1,665 Cr | ₹1,598 Cr | ₹1,424 Cr | ₹1,469 Cr |
Fixed Deposits - Public | - | - | - | - | - |
Loans and advances from subsidiaries | - | - | - | - | - |
Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
Foreign Currency Convertible Notes | - | - | - | - | - |
Long Term Loan in Foreign Currency | - | - | - | - | - |
Loans - Banks | ₹295 Cr | ₹171 Cr | ₹195 Cr | ₹190 Cr | ₹439 Cr |
Loans - Govt. | - | - | - | - | ₹0.70 Cr |
Loans - Others | - | - | - | - | - |
Other Unsecured Loan | ₹1,608 Cr | ₹1,494 Cr | ₹1,403 Cr | ₹1,234 Cr | ₹1,029 Cr |
Deferred Tax Assets / Liabilities | ₹100 Cr | ₹74 Cr | ₹81 Cr | ₹-241 Cr | ₹-275 Cr |
Deferred Tax Assets | ₹1,103 Cr | ₹747 Cr | ₹710 Cr | ₹549 Cr | ₹497 Cr |
Deferred Tax Liability | ₹1,203 Cr | ₹821 Cr | ₹791 Cr | ₹308 Cr | ₹221 Cr |
Other Long Term Liabilities | ₹3,727 Cr | ₹1,876 Cr | ₹5,145 Cr | ₹2,954 Cr | ₹2,705 Cr |
Long Term Trade Payables | - | - | - | - | - |
Long Term Provisions | ₹261 Cr | ₹238 Cr | ₹227 Cr | ₹92 Cr | ₹106 Cr |
Total Non-Current Liabilities | ₹16,493 Cr | ₹15,120 Cr | ₹20,742 Cr | ₹6,803 Cr | ₹5,497 Cr |
Current Liabilities | - | - | - | - | - |
Trade Payables | ₹6,549 Cr | ₹6,272 Cr | ₹3,842 Cr | ₹1,609 Cr | ₹1,514 Cr |
Sundry Creditors | ₹6,549 Cr | ₹6,272 Cr | ₹3,842 Cr | ₹1,609 Cr | ₹1,514 Cr |
Acceptances | - | - | - | - | - |
Due to Subsidiaries- Trade Payables | - | - | - | - | - |
Other Current Liabilities | ₹3,966 Cr | ₹6,481 Cr | ₹1,815 Cr | ₹1,031 Cr | ₹1,840 Cr |
Bank Overdraft / Short term credit | - | - | - | ₹0.20 Cr | ₹9.50 Cr |
Advances received from customers | ₹612 Cr | ₹517 Cr | ₹541 Cr | ₹445 Cr | ₹401 Cr |
Interest Accrued But Not Due | ₹249 Cr | ₹18 Cr | ₹20 Cr | ₹14 Cr | ₹13 Cr |
Share Application Money | - | - | - | - | - |
Current maturity of Debentures & Bonds | - | - | - | - | - |
Current maturity - Others | - | - | - | - | - |
Other Liabilities | ₹3,105 Cr | ₹5,947 Cr | ₹1,254 Cr | ₹573 Cr | ₹1,418 Cr |
Short Term Borrowings | ₹3,455 Cr | ₹2,149 Cr | ₹2,480 Cr | ₹896 Cr | ₹594 Cr |
Secured ST Loans repayable on Demands | ₹325 Cr | ₹42 Cr | ₹103 Cr | ₹38 Cr | ₹56 Cr |
Working Capital Loans- Sec | ₹325 Cr | ₹42 Cr | ₹41 Cr | ₹38 Cr | ₹56 Cr |
Buyers Credits - Unsec | - | - | - | - | - |
Commercial Borrowings- Unsec | - | - | - | - | - |
Other Unsecured Loans | ₹2,805 Cr | ₹2,066 Cr | ₹2,336 Cr | ₹820 Cr | ₹482 Cr |
Short Term Provisions | ₹365 Cr | ₹456 Cr | ₹374 Cr | ₹292 Cr | ₹262 Cr |
Proposed Equity Dividend | - | - | - | - | - |
Provision for Corporate Dividend Tax | - | - | - | - | - |
Provision for Tax | ₹173 Cr | ₹277 Cr | ₹225 Cr | ₹162 Cr | ₹152 Cr |
Provision for post retirement benefits | - | - | - | - | - |
Preference Dividend | - | - | - | - | - |
Other Provisions | ₹192 Cr | ₹180 Cr | ₹149 Cr | ₹131 Cr | ₹109 Cr |
Total Current Liabilities | ₹14,334 Cr | ₹15,359 Cr | ₹8,511 Cr | ₹3,828 Cr | ₹4,210 Cr |
Total Liabilities | ₹58,540 Cr | ₹55,753 Cr | ₹51,742 Cr | ₹20,101 Cr | ₹18,215 Cr |
ASSETS | |||||
Gross Block | ₹40,804 Cr | ₹37,930 Cr | ₹35,321 Cr | ₹11,233 Cr | ₹10,221 Cr |
Less: Accumulated Depreciation | ₹8,841 Cr | ₹7,287 Cr | ₹5,854 Cr | ₹4,664 Cr | ₹3,857 Cr |
Less: Impairment of Assets | - | - | - | - | - |
Net Block | ₹31,963 Cr | ₹30,644 Cr | ₹29,468 Cr | ₹6,569 Cr | ₹6,364 Cr |
Lease Adjustment A/c | - | - | - | - | - |
Capital Work in Progress | ₹4,102 Cr | ₹3,985 Cr | ₹2,588 Cr | ₹3,420 Cr | ₹2,254 Cr |
Non Current Investments | ₹680 Cr | ₹684 Cr | ₹742 Cr | ₹370 Cr | ₹743 Cr |
Long Term Investment | ₹680 Cr | ₹684 Cr | ₹742 Cr | ₹370 Cr | ₹743 Cr |
Quoted | ₹624 Cr | ₹630 Cr | ₹12 Cr | ₹59 Cr | ₹128 Cr |
Unquoted | ₹68 Cr | ₹59 Cr | ₹731 Cr | ₹312 Cr | ₹616 Cr |
Long Term Loans & Advances | ₹871 Cr | ₹893 Cr | ₹683 Cr | ₹484 Cr | ₹436 Cr |
Other Non Current Assets | ₹231 Cr | ₹361 Cr | ₹1,198 Cr | ₹185 Cr | ₹271 Cr |
Total Non-Current Assets | ₹42,253 Cr | ₹40,574 Cr | ₹39,408 Cr | ₹11,718 Cr | ₹10,614 Cr |
Current Assets Loans & Advances | - | - | - | - | - |
Currents Investments | ₹447 Cr | ₹316 Cr | ₹1,327 Cr | ₹1,218 Cr | ₹1,213 Cr |
Quoted | ₹447 Cr | ₹316 Cr | ₹444 Cr | ₹252 Cr | ₹624 Cr |
Unquoted | - | - | ₹882 Cr | ₹966 Cr | ₹589 Cr |
Inventories | ₹4,931 Cr | ₹4,944 Cr | ₹4,244 Cr | ₹2,298 Cr | ₹1,867 Cr |
Raw Materials | ₹968 Cr | ₹837 Cr | ₹896 Cr | ₹602 Cr | ₹478 Cr |
Work-in Progress | ₹1,723 Cr | ₹1,415 Cr | ₹1,371 Cr | ₹1,062 Cr | ₹735 Cr |
Finished Goods | ₹915 Cr | ₹823 Cr | ₹401 Cr | ₹355 Cr | ₹429 Cr |
Packing Materials | ₹430 Cr | ₹280 Cr | ₹377 Cr | ₹254 Cr | ₹203 Cr |
Stores  and Spare | - | - | - | - | - |
Other Inventory | ₹895 Cr | ₹1,590 Cr | ₹1,198 Cr | ₹26 Cr | ₹22 Cr |
Sundry Debtors | ₹5,488 Cr | ₹6,231 Cr | ₹3,573 Cr | ₹2,058 Cr | ₹1,517 Cr |
Debtors more than Six months | ₹498 Cr | ₹900 Cr | ₹326 Cr | ₹95 Cr | ₹19 Cr |
Debtors Others | ₹5,053 Cr | ₹5,396 Cr | ₹3,309 Cr | ₹1,999 Cr | ₹1,511 Cr |
Cash and Bank | ₹4,120 Cr | ₹2,259 Cr | ₹2,400 Cr | ₹1,748 Cr | ₹2,049 Cr |
Cash in hand | - | - | - | - | - |
Balances at Bank | ₹4,120 Cr | ₹2,259 Cr | ₹2,400 Cr | ₹1,748 Cr | ₹2,049 Cr |
Other cash and bank balances | - | - | - | - | - |
Other Current Assets | ₹383 Cr | ₹334 Cr | ₹334 Cr | ₹660 Cr | ₹661 Cr |
Interest accrued on Investments | - | - | ₹56 Cr | ₹62 Cr | ₹27 Cr |
Interest accrued on Debentures | - | - | - | - | - |
Deposits with Government | - | - | - | - | - |
Interest accrued and or due on loans | - | - | - | - | - |
Prepaid Expenses | ₹190 Cr | ₹157 Cr | ₹132 Cr | ₹87 Cr | ₹71 Cr |
Other current_assets | ₹193 Cr | ₹177 Cr | ₹146 Cr | ₹511 Cr | ₹564 Cr |
Short Term Loans and Advances | ₹917 Cr | ₹1,096 Cr | ₹456 Cr | ₹401 Cr | ₹293 Cr |
Advances recoverable in cash or in kind | ₹177 Cr | ₹106 Cr | ₹150 Cr | ₹129 Cr | ₹73 Cr |
Advance income tax and TDS | - | - | - | - | - |
Amounts due from directors | - | - | - | - | - |
Due From Subsidiaries | - | - | - | - | - |
Inter corporate deposits | ₹360 Cr | ₹538 Cr | - | - | - |
Corporate Deposits | - | - | - | - | - |
Other Loans & Advances | ₹381 Cr | ₹452 Cr | ₹306 Cr | ₹272 Cr | ₹220 Cr |
Total Current Assets | ₹16,286 Cr | ₹15,179 Cr | ₹12,334 Cr | ₹8,382 Cr | ₹7,600 Cr |
Net Current Assets (Including Current Investments) | ₹1,952 Cr | ₹-180 Cr | ₹3,823 Cr | ₹4,554 Cr | ₹3,390 Cr |
Miscellaneous Expenses not written off | - | - | - | - | - |
Total Assets | ₹58,540 Cr | ₹55,753 Cr | ₹51,742 Cr | ₹20,101 Cr | ₹18,215 Cr |
Contingent Liabilities | ₹1,176 Cr | ₹1,136 Cr | ₹948 Cr | ₹844 Cr | ₹700 Cr |
Total Debt | ₹17,756 Cr | ₹15,730 Cr | ₹17,771 Cr | ₹4,904 Cr | ₹4,359 Cr |
Book Value | 176.73 | 162.11 | 146.53 | 68.53 | 62.27 |
Adjusted Book Value | 176.73 | 162.11 | 146.53 | 68.53 | 62.27 |
Compare Balance Sheet of peers of BIOCON
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BIOCON | ₹51,200.4 Cr | -0.7% | 6.2% | 10.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹390,864.0 Cr | 0.4% | 1.7% | 2% | Stock Analytics | |
DIVIS LABORATORIES | ₹168,811.0 Cr | -0.3% | -3.8% | 35.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹124,352.0 Cr | 3.9% | 11.8% | 20% | Stock Analytics | |
CIPLA | ₹121,260.0 Cr | 1.5% | 3.8% | 2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,786.0 Cr | -0.5% | -0.1% | -5.1% | Stock Analytics |
BIOCON Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BIOCON | -0.7% |
6.2% |
10.6% |
SENSEX | -1.1% |
-3.4% |
-1.1% |
You may also like the below Video Courses